Cargando…

Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research

Amphetamine (AMP), methylphenidate (MPH), and atomoxetine (ATX) are approved treatments for ADHD, and together with nicotine (NIC), represent pharmacological agents widely studied on cognitive domains including attention and impulsive action in humans. These agents thus represent opportunities for c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higgins, Guy A., Silenieks, Leo B., MacMillan, Cam, Thevarkunnel, Sandy, Parachikova, Anna I., Mombereau, Cedric, Lindgren, Hanna, Bastlund, Jesper F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193984/ https://www.ncbi.nlm.nih.gov/pubmed/32390829 http://dx.doi.org/10.3389/fphar.2020.00427

Ejemplares similares

Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
por: Higgins, Guy A., et al.
Publicado: (2021)

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system
por: Wei, Wei, et al.
Publicado: (2023)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)

Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
por: Fenderson, Joshua L., et al.
Publicado: (2013)

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
por: Suzuki, Shiho, et al.
Publicado: (2020)

Transition from Methylphenidate to Atomoxetine: reasons for switching and clinical outcome
por: Cassar, Fabrizia, et al.
Publicado: (2021)

Targeting impulsivity in Parkinson’s disease using atomoxetine
por: Kehagia, Angie A., et al.
Publicado: (2014)

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
por: Bro, Søren Pauli, et al.
Publicado: (2015)

Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
por: Ekinci, Ozalp, et al.
Publicado: (2020)

Differential Influence of Dopamine Transport Rate on the Potencies of Cocaine, Amphetamine, and Methylphenidate
por: Calipari, Erin S., et al.
Publicado: (2014)

Amphetamine, but not methylphenidate, increases ethanol intake in adolescent male, but not in female, rats
por: Ruiz, Paul, et al.
Publicado: (2018)

Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder
por: Garg, Jasmin, et al.
Publicado: (2015)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
por: Joubert, Liezl, et al.
Publicado: (2018)

Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
por: Kim, Jae Heon, et al.
Publicado: (2023)

Waiting Impulsivity: The Influence of Acute Methylphenidate and Feedback
por: Voon, Valerie, et al.
Publicado: (2015)

Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression
por: Calipari, Erin S., et al.
Publicado: (2013)

Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States
por: Vaddadi, Sneha M., et al.
Publicado: (2021)

Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers
por: Marquand, Andre F, et al.
Publicado: (2011)

Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys
por: Cubillo, Ana, et al.
Publicado: (2014)

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor ‘knockout’ mice
por: Pillidge, Katharine, et al.
Publicado: (2014)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
por: Carlson, Gabrielle A, et al.
Publicado: (2007)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
por: Hong, Jihyung, et al.
Publicado: (2009)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
por: Nakanishi, Yoko, et al.
Publicado: (2017)

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
por: Hanwella, Raveen, et al.
Publicado: (2011)

Surveillance of Diversion and Nonmedical Use of Extended-Release Prescription Amphetamine and Oral Methylphenidate in the United States
por: Sembower, Mark A., et al.
Publicado: (2013)

Adolescent Exposure to Methylphenidate Increases Impulsive Choice Later in Life
por: Abbas, Zarish, et al.
Publicado: (2017)

Characterization of the 5-HT(2C) receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity
por: Higgins, Guy A, et al.
Publicado: (2015)

Cannabinoid CB1 Receptor Activation Mediates the Opposing Effects of Amphetamine on Impulsive Action and Impulsive Choice
por: Wiskerke, Joost, et al.
Publicado: (2011)

Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis
por: Rezaei, Golandam, et al.
Publicado: (2016)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
por: Tahıllıoğlu, Akın, et al.
Publicado: (2020)

‘Waiting impulsivity’ in isolation-reared and socially-reared rats: effects of amphetamine
por: Liu, Yia-Ping, et al.
Publicado: (2017)

Experimental Investigations on Dopamine Transmission Can Provide Clues on the Mechanism of the Therapeutic Effect of Amphetamine and Methylphenidate in ADHD
por: Carboni, Ezio, et al.
Publicado: (2004)

A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate
por: Zimovetz, Evelina A., et al.
Publicado: (2016)

Shared and Unique Effects of Long-Term Administration of Methylphenidate and Atomoxetine on Degree Centrality in Medication-Naïve Children With Attention-Deficit/Hyperactive Disorder
por: Fu, Zhao, et al.
Publicado: (2022)

Nicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice123
por: Storey, Granville P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jgnjhpjn2l1ldgg7elb449qsco